Sagent Pharmaceuticals, Inc. 4
4 · Sagent Pharmaceuticals, Inc. · Filed Feb 27, 2015
Insider Transaction Report
Form 4
Patterson Albert
Senior VP, Operations
Transactions
- Award
Common Stock
2015-02-25+4,420→ 36,996 total - Award
Stock Option to Buy
2015-02-25+8,208→ 8,208 totalExercise: $27.15Exp: 2025-02-25→ Common Stock (8,208 underlying)
Footnotes (1)
- [F1]The option vests in four equal installments beginning on February 25, 2016.